Vector-borne agents comprise medically important infections affecting dogs throughout much of the world. Sensitive detection of antibodies directed at tick-borne disease-causing organisms in dogs is diagnostically important for veterinarians, pets and their owners, and epidemiologically important for public health surveillance. The SNAP 4Dx Plus Test (IDEXX Laboratories, Inc., Westbrook, ME) identifies antibodies to or infection with multiple tick-borne pathogens and canine heartworm antigen in a single assay. Recently, VetScan FLEX4 Rapid Test (Abaxis, Inc., Union City, CA) was launched as a new assay to detect tick-borne pathogen antibodies and heartworm antigen. In the present study, we evaluated the comparative performance of SNAP 4Dx Plus (SNAP) and FLEX4 Rapid Test (FLEX4) using samples selected based on geographic distributions for canine vector borne diseases, including Borrelia burgdorferi (n = 105), Anaplasma phagocytophilum (160), Anaplasma platys (115), Ehrlichia canis (154), Ehrlichia ewingii (163), Ehrlichia chaffeensis (151) and Dirofilaria immitis (105). Canine vector borne diseases infection status was established for each sample by a combination of reference methods that included necropsy (D. immitis, heartworm disease), Western immunoblotting (B. burgdorferi), immunofluorescence assays (A. phagocytophilum and E. canis) and species-specific ELISAs (A. platys, E. canis, E. ewingii and E. chaffeensis). For comparisons among the 2 assays, samples were evaluated per the manufacturers' instructions for each test kit. By testing each same sample set compared to the defined reference results, sensitivities differed substantially between SNAP and FLEX4, at 95.5 vs. 40.9%, respectively for B. burgdorferi, 97.1% vs. 61.4% for E. canis, 98.2% vs. 59.3% for E. ewingii, 64.3% vs. 35.7% for E. chaffeensis, 84.5% vs. 12.7% for A. phagocytophilum, 83.3% vs. 33.3% for A. platys, and 94.1% vs. 88.2% for D. immitis. Specificities for both rapid assay tests ranged from 98% to 100%. Based upon the comparative results derived from this study, the SNAP test was more sensitive than the FLEX4 test for detection of antibodies to all tick-borne pathogens and heartworm disease (Dirofilaria immitis) antigen in dogs.
Introduction
Canine vector-borne diseases (CVBD), including Lyme disease, ehrlichiosis, and anaplasmosis are becoming increasingly prevalent as tick distributions expand through climate change, wildlife migration, and increased relocation of companion animals throughout the world.1 Both dogs and humans are susceptible to tick-transmission of Borrelia burgdorferi, Anaplasma phagocytophilum, Anaplasma platys, Ehrlichia canis, Ehrlichia ewingii, Ehrlichia chaffeensis, and mosquito transmission of Dirofilaria immitis. As many of these organisms can cause disease in dogs and humans, comprehensive screening for CVBD exposure and/or infection in dogs is diagnostically important for veterinarians and epidemiologically important for public health surveillance and vector control interventions. 1, 2 In the United States, canine granulocytic anaplasmosis is an emerging tick-borne disease affecting cats, dogs, horses, and humans. 2 A. phagocytophilum is transmitted by Ixodes spp. located in the upper Midwest, New England, parts of the Mid-Atlantic States, and northern California. A. phagocytophilum infects neutrophils of dogs and other animal species. 1 Clinical disease in dogs occurs during the acute phase of infection, when morulae are more likely to be seen in the blood smears. 2, 3 In addition to morulae detection by microscopy and PCR amplification of A. phagocytophilum DNA, other methods of diagnosis of canine granulocytic anaplasmosis include antibody detection using whole A. phagocytophilum organisms in immunofluorescence (IFA) assay and bacterial antigens in ELISA assays. 1,2 IFA assays detect antibodies directed against A. phagocytophilum or A. platys.
2,3
A. platys causes cyclic canine thrombocytopenia and Rhipicephalus sanguineus has been proposed as the vector for transmission of this organism. 4 Dogs infected with A. platys are generally found in areas where E. canis infection is prevalent and coinfection with both organisms have been documented in dogs. 5, 6 Clinical cases of confirmed coinfection with A. platys and E. canis have been described. 7, 8 In one study, dogs experimentally coinfected with A. platys and E. canis had more severe thrombocytopenia than dogs infected with either organism alone. 8 Canine Lyme disease is caused by B. burgdorferi, which is also transmitted by Ixodes spp. B. burgdorferi is the most common vectorborne disease agent affecting humans in the United States. 9 Clinical signs for Lyme disease in dogs include lameness, anorexia, and lethargy. While traditional methods like whole cell ELISA and IFA have been used to diagnose Lyme disease in dogs, detection of antibodies against C6 peptide is considered highly specific for natural infection with B. burgdorferi and anti-C6 antibodies are absent from dogs vaccinated with commercial vaccines. 10 Several Ehrlichia species infect dogs in North America. 16, 17 Clinical signs in dogs infected with E. ewingii can be similar to E. canis, including fever, lethargy, anorexia, lameness (polyarthritis), and in some cases severe thrombocytopenia. [17] [18] [19] [20] [21] [22] As E. ewingii organisms have not been cultured in vitro, serologic tests either based on whole cell ELISA or IFA assays are not available. Diagnostically, E. ewingii morulae can be visualized in granulocytes (also true for A. phagocytophilum morulae) and E. chaffeensis in monocytes in Giemsa stained blood smears, particularly during the acute infection phase. 1, 16, 18 Diagnostic sensitivity in chronic E. ewingii and E. chaffeensis infections has been improved by development of targeted PCR tests. 15 By incorporation of an E. ewingii-specific peptide, the SNAP assay was the first commercial in-clinic serologic test developed for rapid detection of E. ewingii antibody, as well as monocytic Ehrlichia spp. antibodies. 11, 14, 21 Canine heartworm disease, transmitted by mosquitoes, is widely distributed throughout the United States. [22] [23] [24] [25] Heartworm disease can be fatal if left untreated. While heartworm infected dogs may have clinical signs that include coughing, lethargy, and exercise intolerance, dogs can be subÀclinically-infected with no clinical signs, which is a common occurrence in highly endemic heartworm disease areas. 22, 23 There are several commercially available heartworm antigen tests, most of which detect circulating carbohydrate antigens and are used to diagnose occult or clinical canine heartworm infections. 24 Sensitive detection of heartworm and tick-borne diseases in dogs, including coinfections with multiple vector borne organisms, is diagnostically important for veterinarians, pets, and their owners and epidemiologically important for public health surveillance, as some of these vector borne organisms can infect both dogs and humans. 1 The SNAP assay (IDEXX Laboratories, Inc., Westbrook, ME) is an in-clinic rapid ELISA that has been validated extensively for simultaneous detection of antibodies to A. phagocytophilum, A. platys, E. canis, E. ewingii, B. burgdorferi, and D. immitis (heartworm) antigen. [26] [27] [28] [29] [30] The FLEX4 assay (Abaxis, Union City, CA) recently became commercially available for detection of antibodies to vector-borne pathogens and heartworm antigen in dogs. FLEX4 is a 2-strip lateral flow assay with 1 strip detecting heartworm antigen and Ehrlichia spp. antibody while the second strip detects Anaplasma spp. and B. burgdorferi antibodies. There are no published reports comparing the performance of these 2 in-clinic assays using diagnostically well characterized samples by "gold standard" or reference assays. In the current study, we compared the performance of each assay for the detection of antibodies to CVBD organisms and heartworm antigen in dogs.
Materials and Methods
As described below, a total of 844 serum or plasma samples were identified for comparative evaluation. Samples were stored in a ¡20°C freezer until tested.
Ehrlichia canis IFA Sample Set
This sample set consisted of E. canis IFA seroreactive (n = 68) and IFA nonseroreactive (n = 86) specimens originally submitted to commercial reference laboratories (IDEXX Laboratories, Inc., Westbrook, ME) for diagnostic testing from clinics in the Southwestern United States (n = 47) and Europe (n = 107). E. canis seroreactive titers ranged from 1:100 to 3200. Specimens were further confirmed to contain E. canis-specific antibodies using a peptide-based species-specific ELISA. 31 Patient information was not available for these samples.
Ehrlichia ewingii and Ehrlichia chaffeensis Sample Set
Serum or plasma samples obtained from A. americanum-endemic regions of the United States were retrospectively screened for E. ewingii and E. chaffeensis specific antibodies. Most of these samples were collected at a private clinic in Arkansas, as a component of a national seroprevalence study. 32 Dogs included in this sample set were tested as a component of routine veterinary care at the sole discretion of the attending veterinarian.
To identify monospecific E. ewingii reactive sera (n = 54) and monospecific E. chaffeensis reactive sera (n = 42), samples were screened using previously described peptide-based species-specific assays for E. canis and E. chaffeensis. 31 An E. ewingii-specific recombinant protein based ELISA was also used to assess E. ewingii seroreactivity. 14, 31, 32 By design, the reagents (peptides or recombinant protein) used in each of these three screening assays were molecularly distinct from those used in the SNAP test. 26 To our knowledge, the reagents used in the FLEX4 test have not been disclosed to allow for similar assessment. Following screening with the 2 speciesspecific peptides and the recombinant protein ELISA, Ehrlichia nonseroreactive samples (n = 109) were randomly chosen for inclusion in this study.
Anaplasma phagocytophilum and Borrelia burgdorferi Sample Set
Samples used for A. phagocytophilum and B. burgdorferi evaluation were geographically limited to northeast and upper Midwest United States, including clinical submissions to a commercial reference laboratory (IDEXX Laboratories, Inc.) for tick panel testing (IFA) and samples collected at a private veterinary clinic in Minnesota as part of routine wellness screening by attending veterinarians. A. phagocytophilum IFA seroreactive samples (n = 71) with titers ranging from 1:50 to 3200 and IFA nonseroreactive (n = 89) samples were selected to assess assay sensitivities and specificities. Lyme disease Western immunoblotting was performed using the Borrelia Veterinary plus OspA Line test kit (Virotech Diagnostics, Germany), 33 and resulted in identification of specimens with evidence for B. burgdorferi sensu lato exposure and/or infection (n = 44) or no WB serologic evidence for exposure to this vector-borne pathogen (n = 61).
Anaplasma platys Sample Set
The A. platys sample set consisted of sera collected during a seroprevalence study involving dogs in the southwestern United States (Hopi Reservation, AZ), where R. sanguineus is the only known tick species inhabiting this locality. 5 A peptide-based species-specific ELISA 31 was used to identify A. platys reactive (n = 36) and A. platys non-reactive sera (n = 79).
Dirofilaria immitis Sample Set
Samples for D. immitis antigen evaluation consisted of samples (n = 51) from dogs with necropsy confirmed D. immitis adult worms, including 23 samples from dogs with 1-3 female worms. 26, 27 Because of ethical concerns, D. immitis negative samples (n = 54) were obtained from clinical submissions to the IDEXX Reference Laboratories for D. immitis antigen testing by PetChek HW PF (IDEXX Laboratories, Inc.).
Comparative Testing of the In-Clinic Rapid Assays
To compare the sensitivity and specificity of the SNAP and FLEX4 assays, plasma or serum samples were randomized, blind-labeled and tested using each rapid assay. Testing and visual interpretation of results were performed by 3 different operators (who were blinded to confirmatory assay test results) as the per manufacturers' kit instructions. The test results were compared to reference method results for calculation of sensitivity and specificity. A test was considered invalid and the data discarded if the assay control line in the FLEX4 assay or the positive control spot in the SNAP assay failed to develop color during the assay run.
Statistical Analysis
Sensitivity and specificity of rapid assays for each infection were determined based on the reference assay results. The Exact ClopperPearson method was used to calculate 95% confidence intervals of sensitivity and specificity estimate. Statistical significance between sensitivity differences of the 2 rapid assays was determined by Exact McNemar's test, at an alpha level of 0.007 which was adjusted from a = 0.05 for 7-assay comparisons using the Bonferroni correction.
Results

Sensitivity and Specificity
A total of 844 samples were tested using the SNAP and FLEX4 assays. Both assays were independently read by 3 readers. No invalid test results were obtained with either assay. As described in the Methods, all samples were preselected for this evaluation based on geographic location and IFA, WB and/or species-specific ELISA. Necropsy and PetChek ELISA testing were used to identify heartworm antigen positive and negative samples, respectively. Sensitivity and specificity data for SNAP and FLEX4 assays (as compared with reference test results) are summarized in Table 1 .
Using A. phagocytophilum characterized samples obtained from I. scapularis endemic areas, the sensitivity of SNAP and FLEX4 assays were 84.5% and 12.7%, respectively. Of the 89 IFA negative samples, 88 samples were negative by both in-clinic tests indicating similar specificity for both assays. Performance of both assays for A. phagocytophilum antibody detection using samples with different titer levels for all IFA seropositive samples were plotted (Fig 1) . Of the 71 A. phagocytophilum IFA seropositive samples, the FLEX4 assay gave false negative test results for more than 70% of the samples across every titer range. SNAP sensitivity was significantly higher across all titer groups. Of the 115 samples that were characterized geographically (Arizona, R. sanguineus endemic) and by species-specific ELISA for anti-A platys antibodies, the sensitivity of SNAP and FLEX4 assays were 83.3% and 33.3%, respectively. The A. platys specificities for both in-clinic assays ranged from 96.2% to 98.7%.
Of the 44 samples that tested Western immunoblot positive for B. burgdorferi antibodies, 42 were positive by SNAP assay (sensitivity = 95.5%) while FLEX4 had positive test results in 18 samples with a calculated sensitivity of 40.9%. Both tests had a B. burgdorferi specificity of 100%.
Of the 154 samples that were E. canis positive by IFA and speciesspecific ELISA, the sensitivity for SNAP and FLEX4 tests were 97.1% and 61.4%, respectively, with a specificity of 100% for both assays. Like the A. phagocytophilum analyte, the FLEX4 assay had 30% false negative E. canis test results across different IFA antibody titer ranges (Fig 2) . The 24 FLEX4 false negative E. canis test results were E. canis IFA, SNAP assay, and p16-based E. canis species-specific antibody ELISA positive. 31 A recombinant protein species-specific ELISA for E. ewingii was used as the reference test in determining the sensitivity and specificity for both in-clinic test kits. 31 The sensitivity of SNAP and FLEX4 for anti-E. ewingii antibody detection was 98.2% and 59.3%, respectively. SNAP had a specificity of 100% for this sample set, whereas FLEX4 specificity was 98.2%. Ehrlichia chaffeensis antibody positive and negative samples (n = 151) were characterized using a previously described E. chaffeensis specific assay. 19, 31 Of the 42 positive samples tested by the species-specific assay, 27 samples were positive by the SNAP assay compared to 15 samples that tested positive by the FLEX4 assay. The sensitivity for the SNAP and FLEX4 assay was 64.3% and 35.7%, and the specificity for SNAP was 100% compared to 98% for FLEX4 assay. Serum samples for 48 of 51 dogs with necropsy-confirmed heartworm infection tested antigen positive by SNAP while 45 of 51 samples were positive by the FLEX4 assay resulting in the sensitivity of 94.1% for SNAP vs. 88.2% for the FLEX4 assay. All 54 samples that A. phagocytophilum Reciprocal IFA Titers were negative by use of reference assay, tested negative on both SNAP and FLEX4 assays (specificity = 100%).
Based on the results of the current study, using samples characterized based on reference tests, the SNAP test demonstrated significantly higher overall sensitivity than the FLEX4 test (P < .0007) for A. phagocytophilum, A. platys, B. burgdorferi and all 3 Ehrlichia spp. antibody detection. There was no statistical difference between the 2 assays for heartworm antigen detection (P = .375).
Discussion
The ability of an in-clinic rapid assay to accurately detect antibodies against an organism or their antigens is dependent on several factors. The reagents used in the assays must be analyte-specific and should have very high sensitivity for the detection of antibodies or antigen. In addition, for multiplex assays, the reagents should not crossreact or interfere with the other analytes used on the same device. 34 Despite developing acute-onset clinical illness, dogs infected with A. phagocytophilum may not have mounted an antibody response sufficiently strong to be detected by any serologic test. 1, 3, 9 In our study, samples from dogs with anti-A. phagocytophilum antibodies, as determined by IFA, were used as reference sample sets to compare the sensitivity and specificity of the 2 assays. Compared to the FLEX4 assay, the SNAP assay had significantly higher sensitivity for detection of A. phagocytophilum antibodies (84.5% for SNAP vs. 12.7% for FLEX4) (P < .0007). The FLEX4 assay also had variable performance across all IFA titer ranges indicating that use of FLEX4 in field situations would result false negative results in A. phagocytophilum infected or exposed dogs. As described in the methods, A. platys samples collected from dogs living in the southwestern United Sates (Hopi Reservation, AZ) were screened using a previously validated species-specific ELISA. 5, 31 This species-specific ELISA uses an A. platys specific peptide reagent that differs from the p30 peptide used in the SNAP assay. 27 Thus, using A.
platys-specific sample sets, the FLEX4 assay had a sensitivity of 33% compared to SNAP, indicating that the FLEX4 test will generate over 50% A. platys false negative test results. Poor performance of the FLEX4 assay for both Anaplasma spp. will impact the use of this assay as a screening test for epidemiologic purposes, as a tool for veterinarians to assess the compliance or effectiveness of acaracide administration, and will also limit the diagnostic utility when testing sick animals suspected of anaplasmosis or cyclic canine thrombocytopenia, caused by A. platys.
Compared to the SNAP assay, the FLEX4 assay had a lower sensitivity for detection B. burgdorferi antibodies in dogs. While, several prior studies have used whole B. burgdorferi organisms, commonly referred to as whole-cell antigen-based ELISA and IFA, as reference tests for sample selection, 9, 27 in the present study, a Western immunoblot assay was used to enhance the diagnostic accuracy of the sample sets used for comparison testing. In addition, the Western immunoblot assay can also discriminate between naturally-infected and vaccinated dogs based on their respective banding patterns. 32 The C6 peptide in the SNAP assay is not recognized due to prior vaccination. 10 Using the sample set defined in this study, the SNAP assay had a sensitivity of 95.5% for the detection of B. burgdorferi antibodies compared to the FLEX4 assay which had a lower sensitivity of 40%. Thus, the FLEX4 assay could lead to greater than 50% false negative test results when used as an in-clinic test to screen healthy dogs or to test clinically-ill dogs in a Lyme endemic area.
In this study, a species-specific ELISA was used to differentiate Ehrlichia species that have overlapping geographic distributions within the United States. 14, 33 To further enhance monospecific identification of E. canis samples, a subset of samples from dogs in Europe were tested where E. ewingii, E. chaffeensis and their competent tick vectors have not been reported. 34 In this study, the SNAP assay sensitivity for detection of E. canis antibodies was 97.1%, which agrees with previous studies that reported both high sensitivity and specificity. [26] [27] [28] [29] [30] 33 Using this sample set, SNAP was significantly more sensitive than the FLEX4 assay for E. canis (97.1% for SNAP vs. 61.4% for FLEX4) (P < .0007). In addition, a substantial number (n = 17 out of 57) of E. canis antibody positive high-titer samples (>1:1280) that were also positive on species-specific E. canis ELISA were falsely negative using the FLEX4 assay. The 2 antigens used to detect antiehrlichial antibodies in the SNAP assay are immunodominant peptides derived from well-characterized surface proteins of E. canis, E. chaffeensis, and E. ewingii.
26,33
Peer-reviewed data are not currently available for the performance of the FLEX4 assay and the nature of antigen(s) used in FLEX4 assay have not been published. Based upon recent evidence, diagnostic detection of Ehrlichia spp. antibodies in dogs is important in the United States, as infections with these Ehrlichia spp. are increasingly being diagnosed. A. americanum is an aggressive tick feeder that is often found in high numbers and is spreading rapidly to previously nonendemic regions within the United States. 14, 19, 21 Prior assays used to diagnose ehrlichiosis, such as whole-cell crude lysates and IFA using cell culture grown E. canis, have limitations related to antigenic recognition and differentiation among Ehrlichia spp. infecting dogs. 2, 33 For example, serologic crossreactivity between E. canis, E. ewingii, and E. chaffeensis has been reported with E. canis IFA assays. 35 In the present study, a speciesspecific recombinant antigen-based assay was used as the reference test in evaluating sensitivity and specificity of both in-clinic assays for detection of anti-E. ewingii antibodies. 31 When monospecific E. ewingii seroreactive samples were selected to evaluate the performance, SNAP had a sensitivity and specificity of 98.2 compared to 59.3% for the FLEX4 assay. Although the FLEX4 assay has a product claim for detection of E. chaffeensis antibodies, the SNAP assay was more sensitive despite the lack of a product claim for E. chaffeensis antibody detection. Testing for canine heartworm antigen is the preferred diagnostic modality for subclinical infections in dogs (annual wellness screening) or to verify the presence of adult heartworms in symptomatic dogs. 22, 23 Antigen tests detect carbohydrate antigens primarily released by the adult female heartworm and are widely used by veterinarians to diagnose canine heartworm infections.22 Currently, antigen-based tests are available as in-clinic assays as well as assays commercially available at many veterinary diagnostic laboratories. 4 According to American Heartworm Society Guidelines, an in-clinic heartworm test should have high sensitivity and specificity. 25 In the current study, both SNAP and FLEX4 had 100% specificity; however, the sensitivity of the FLEX4 was lower than SNAP (88% for FLEX4 and 94% for SNAP). Several factors can affect the diagnostic accuracy of heartworm antigen detection tests, including number of heartworms, worm sex ratio, and presence of immature or dying adult heartworms. 23, 24 There was no statistically significant difference in the sensitivity of SNAP and FLEX4 assays for heartworm antigen detection; however, false negative test results with either assay could result in misdiagnosis of heartworm infected dogs. The ability of an in-clinic assay to rapidly and accurately determine exposure to or infection with 1 or more vector-borne pathogens is important for clinicians who evaluate dogs with clinical signs indicative of a vector-borne infection and when determining if coexposures and/or infections require different treatment or management considerations. In addition, the capacity to identify exposure to multiple tick-borne pathogens will aid veterinarians epidemiologically in defining the prevalence of exposure to a larger spectrum of tick-borne pathogens that are transmitted by Ixodes spp., A. americanum, and R. sanguineous.
1,2,16,36,37 Coinfection with B. burgdorferi and A. phagocytophilum or E. canis and A. platys have been reported to increase the severity of illness in dogs. 8, 37, 38 Veterinarians are increasingly identifying dogs with multiple simultaneous vector-borne infections that appear to be more likely to develop disease manifestations and can have more pronounced pathology involving internal organs. [37] [38] Thus, the overall accuracy (i.e., sensitivity and specificity) of an in-clinic assay is critical in order to be useful as a screening test for vector-borne exposures among healthy dogs or to diagnose a vector-borne disease in a clinically symptomatic dog.
Conclusions
The accuracy of any in-clinic test is of critical importance to veterinarians, pets, and clients when determining exposure to or infection with 1 or more vector-borne pathogens. Based upon the comparative results derived from this study, the SNAP assay is a more sensitive inhouse rapid assay than FLEX4 for the detection of A. phagocytophilum, A. platys, B. burgdorferi, E. canis, E. ewingii, E. chaffeensis antibodies, and heartworm antigen in dogs.
